Filter search criteria using below inputs
Click on magnifying glass icon to search
Company | Country | Symbol |
---|
Time | Volume | ALKS |
---|---|---|
09:32 ET | 248176 | 25.35 |
09:34 ET | 2370 | 25.03 |
09:36 ET | 7000 | 25.295 |
09:38 ET | 1791 | 25.33 |
09:39 ET | 2411 | 25.26 |
09:41 ET | 4056 | 25.23 |
09:43 ET | 3197 | 25.33 |
09:45 ET | 3703 | 25.28 |
09:48 ET | 4314 | 25.33 |
09:50 ET | 1400 | 25.455 |
09:52 ET | 3597 | 25.39 |
09:54 ET | 5126 | 25.265 |
09:56 ET | 2874 | 25.31 |
09:57 ET | 3502 | 25.18 |
09:59 ET | 3412 | 25.26 |
10:01 ET | 4398 | 25.25 |
10:03 ET | 2345 | 25.22 |
10:06 ET | 4312 | 25.22 |
10:08 ET | 6686 | 25.14 |
10:10 ET | 3270 | 25.11 |
10:12 ET | 3100 | 25.1 |
10:14 ET | 1408 | 25.055 |
10:15 ET | 4328 | 25.01 |
10:17 ET | 5196 | 25.02 |
10:19 ET | 4100 | 25.02 |
10:21 ET | 3859 | 25.01 |
10:24 ET | 3379 | 25.03 |
10:26 ET | 1200 | 25.03 |
10:28 ET | 5382 | 25.01 |
10:30 ET | 5978 | 25.03 |
10:32 ET | 14511 | 25.08 |
10:33 ET | 7267 | 25.1 |
10:35 ET | 5816 | 25.16 |
10:37 ET | 6894 | 25.12 |
10:39 ET | 7614 | 25.13 |
10:42 ET | 10017 | 25.11 |
10:44 ET | 10093 | 25.16 |
10:46 ET | 9556 | 25.21 |
10:48 ET | 5567 | 25.155 |
10:50 ET | 12355 | 25.15 |
10:51 ET | 7735 | 25.17 |
10:53 ET | 7486 | 25.19 |
10:55 ET | 10759 | 25.16 |
10:57 ET | 7973 | 25.18 |
11:00 ET | 6311 | 25.08 |
11:02 ET | 9407 | 25.145 |
11:04 ET | 6823 | 25.1 |
11:06 ET | 8720 | 25.14 |
11:08 ET | 14217 | 25.125 |
11:09 ET | 13020 | 25.08 |
11:11 ET | 9780 | 25.07 |
11:13 ET | 9000 | 25.03 |
11:15 ET | 9042 | 25.06 |
11:18 ET | 7603 | 25.08 |
11:20 ET | 7768 | 25.08 |
11:22 ET | 6997 | 25.09 |
11:24 ET | 9934 | 25.07 |
11:26 ET | 7113 | 25.1 |
11:27 ET | 4903 | 25.055 |
11:29 ET | 12138 | 25.06 |
11:31 ET | 8489 | 25.03 |
11:33 ET | 8014 | 25.01 |
11:36 ET | 11196 | 25.015 |
11:38 ET | 9025 | 25.015 |
11:40 ET | 9687 | 25.06 |
11:42 ET | 4953 | 25.06 |
11:44 ET | 6765 | 25.015 |
11:45 ET | 11745 | 25.04 |
11:47 ET | 7178 | 25.04 |
11:49 ET | 9320 | 25.05 |
11:51 ET | 7532 | 25.055 |
11:54 ET | 8739 | 25.045 |
11:56 ET | 5000 | 25.04 |
11:58 ET | 3809 | 25.015 |
12:00 ET | 8822 | 25.02 |
12:02 ET | 9623 | 25.02 |
12:03 ET | 5892 | 25.03 |
12:05 ET | 5107 | 25.01 |
12:07 ET | 13453 | 25.04 |
12:09 ET | 5805 | 25.04 |
12:12 ET | 7105 | 25.04 |
12:14 ET | 8525 | 25.07 |
12:16 ET | 4558 | 25.04 |
12:18 ET | 9808 | 25.04 |
12:20 ET | 9310 | 25.01 |
12:21 ET | 11284 | 25.05 |
12:23 ET | 5140 | 25.04 |
12:25 ET | 3810 | 25.05 |
12:27 ET | 9817 | 25.06 |
12:30 ET | 5350 | 25.04 |
12:32 ET | 8971 | 25.06 |
12:34 ET | 7050 | 25.07 |
12:36 ET | 3359 | 25.065 |
12:38 ET | 13155 | 25.09 |
12:39 ET | 10951 | 25.1 |
12:41 ET | 7990 | 25.11 |
12:43 ET | 6137 | 25.09 |
12:45 ET | 5901 | 25.09 |
12:48 ET | 9320 | 25.095 |
12:50 ET | 6909 | 25.1 |
12:52 ET | 4069 | 25.09 |
12:54 ET | 11806 | 25.09 |
12:56 ET | 8158 | 25.09 |
12:57 ET | 5019 | 25.1 |
12:59 ET | 4360 | 25.1 |
01:01 ET | 8095 | 25.11 |
01:03 ET | 5500 | 25.11 |
01:06 ET | 7510 | 25.135 |
01:08 ET | 5796 | 25.13 |
01:10 ET | 4370 | 25.13 |
01:12 ET | 9811 | 25.145 |
01:14 ET | 5966 | 25.145 |
01:15 ET | 6410 | 25.145 |
01:17 ET | 4585 | 25.14 |
01:19 ET | 3400 | 25.14 |
01:21 ET | 4535 | 25.12 |
01:24 ET | 7069 | 25.055 |
01:26 ET | 16645 | 25.09 |
01:28 ET | 2847 | 25.1 |
01:30 ET | 13017 | 25.075 |
01:32 ET | 5992 | 25.07 |
01:33 ET | 5809 | 25.075 |
01:35 ET | 13455 | 25.1113 |
01:37 ET | 7814 | 25.11 |
01:39 ET | 11456 | 25.12 |
01:42 ET | 5319 | 25.105 |
01:44 ET | 6261 | 25.11 |
01:46 ET | 14551 | 25.11 |
01:48 ET | 5399 | 25.11 |
01:50 ET | 7786 | 25.11 |
01:51 ET | 11375 | 25.12 |
01:53 ET | 7200 | 25.105 |
01:55 ET | 7993 | 25.11 |
01:57 ET | 7193 | 25.125 |
02:00 ET | 6674 | 25.11 |
02:02 ET | 7574 | 25.075 |
02:04 ET | 6399 | 25.065 |
02:06 ET | 12433 | 25.02 |
02:08 ET | 19650 | 25.05 |
02:09 ET | 4490 | 25.04 |
02:11 ET | 4827 | 25.05 |
02:13 ET | 7320 | 25.035 |
02:15 ET | 4045 | 25.025 |
02:18 ET | 13836 | 25.05 |
02:20 ET | 7547 | 25.02 |
02:22 ET | 5588 | 25.02 |
02:24 ET | 8566 | 25.01 |
02:26 ET | 20729 | 25.02 |
02:27 ET | 3500 | 25.03 |
02:29 ET | 4170 | 24.995 |
02:31 ET | 5641 | 24.995 |
02:33 ET | 11258 | 24.985 |
02:36 ET | 419392 | 25.03 |
02:38 ET | 10000 | 25.04 |
02:40 ET | 12022 | 25.05 |
02:42 ET | 6404 | 25.04 |
02:44 ET | 9939 | 25.03 |
02:45 ET | 5686 | 25.03 |
02:47 ET | 5957 | 25.02 |
02:49 ET | 5728 | 25 |
02:51 ET | 5987 | 25 |
02:54 ET | 12989 | 24.995 |
02:56 ET | 9099 | 25.005 |
02:58 ET | 8852 | 24.98 |
03:00 ET | 13918 | 24.975 |
03:02 ET | 18980 | 24.935 |
03:03 ET | 14264 | 24.94 |
03:05 ET | 8555 | 24.93 |
03:07 ET | 5612 | 24.92 |
03:09 ET | 10656 | 24.88 |
03:12 ET | 9504 | 24.9062 |
03:14 ET | 9521 | 24.88 |
03:16 ET | 9209 | 24.88 |
03:18 ET | 7765 | 24.88 |
03:20 ET | 35229 | 24.92 |
03:21 ET | 5319 | 24.895 |
03:23 ET | 11351 | 24.895 |
03:25 ET | 5490 | 24.9 |
03:27 ET | 10725 | 24.85 |
03:30 ET | 17596 | 24.9125 |
03:32 ET | 13009 | 24.91 |
03:34 ET | 18166 | 24.985 |
03:36 ET | 11393 | 24.96 |
03:38 ET | 12987 | 25 |
03:39 ET | 17293 | 25 |
03:41 ET | 17811 | 24.975 |
03:43 ET | 20896 | 24.96 |
03:45 ET | 16157 | 24.92 |
03:48 ET | 25980 | 24.95 |
Company sortable | Market Cap sortable | P/E Ratio (TTM) sortable | EPS Growth (5yr) sortable |
---|---|---|---|
Alkermes Plc | 4.2B | 7.1x | --- |
Exelixis Inc | 6.3B | 34.2x | -21.77% |
PTC Therapeutics Inc | 2.6B | -4.6x | --- |
P3 Health Partners Inc | 190.1M | -1.0x | --- |
Novavax Inc | 2.0B | -4.3x | --- |
Qiagen NV | 9.3B | 27.7x | +12.66% |
Alkermes plc is a global biopharmaceutical company that seeks to develop medicines in the field of neuroscience. The Company has a portfolio of commercial products for the treatment of alcohol dependence, opioid dependence, schizophrenia and bipolar I disorder and a pipeline of clinical and preclinical candidates in development for neurological disorders. It focuses on commercial products, such as LYBALVI, ARISTADA/ARISTADA INITIO and VIVITROL, and advancing the development of pipeline programs focused on neurological disorders. LYBALVI is a once-daily, oral atypical antipsychotic drug for the treatment of adults with schizophrenia and for the treatment of adults with bipolar I disorder, as a maintenance monotherapy or for the acute treatment of manic or mixed episodes, as monotherapy or an adjunct to lithium or valproate. ARISTADA is an extended-release intramuscular injectable suspension for the treatment of schizophrenia. It has a manufacturing facility in Wilmington, Ohio.
Our Ratings feature offers company-specific research ratings from providers such as First Call, S&P and Argus.
Open a New Account, or Login if you're a client.
You have access to a comprehensive selection of independent research reports from providers such as TD Securities, S&P, INK, and Argus.
Open a New Account, or Login if you're a client.
Market Cap | $4.2B |
---|---|
Revenue (TTM) | $1.7B |
Shares Outstanding | 169.2M |
Dividend Yield | 0.00% |
Annual Dividend Rate | --- |
Ex-Dividend Date | 01-01-01 |
Pay Date | 01-01-01 |
Beta | 0.44 |
EPS | $3.50 |
Book Value | $7.20 |
P/E Ratio | 7.1x |
Price/Sales (TTM) | 2.5 |
Price/Cash Flow (TTM) | 6.4x |
Operating Margin | 29.25% |
Our Calendar feature allows you to view a wide selection of market and company events, including earnings, dividends, splits, rating changes, guidance, and more. Access past, current and future events in WebBroker.
Open a New Account, or Login if you're a client.